Bill & Melinda Gates Foundation
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 14, 2024), Bill & Melinda Gates Foundation reported 8 stock positions worth $84.1 million. Its top holding was Immunocore Holdings PLC-ADR (IMCR) at 44.6% of the portfolio, followed by Vir Biotechnology (VIR, 18.8%) and Biontech SE-ADR (BNTX, 16.3%). Compared with Q4 2023, it reduced 1. The biggest sale was Curevac (CVAC, shares −2%).
- Most Recent 13F
- Q3 2024
- Location
- SEATTLE, WA
- CIK
- 0001663801
- Portfolio Value
- $84.1M (Q1 2024)
- SEC Filing
- 0000898432-24-000405 ↗ filed May 14, 2024
Holdings Value
Holdings 8 stocks · $84.1M
| IMCR Immunocore Holdings PLC-ADR | 44.58% | 576,923 | $37.5M | No change |
| VIR Vir Biotechnology Inc. | 18.77% | 1,559,142 | $15.8M | No change |
| BNTX Biontech SE-ADR | 16.30% | 148,674 | $13.7M | No change |
| EXAI Exscientia Ltd. | 10.82% | 1,590,909 | $9.1M | No change |
| CVAC Curevac NV | 7.98% | 1,597,637 | $6.7M | Reduce -1.7% |
| BFLY Butterfly Network Inc. | 1.30% | 1,011,003 | $1.1M | No change |
| LMDXF Lumiradx Ltd. | 0.17% | 14,285,714 | $143K | No change |
| BCEL Atreca Inc. Class A | 0.09% | 912,642 | $73K | No change |
Portfolio Sells Q4 2023 → Q1 2024
| CVAC Curevac NV | Reduce -1.7% | 7.98% | +0.38 |
Portfolio Buys Q4 2023 → Q1 2024
| None this quarter. | |||